Equities

Diversified Healthcare Trust

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Diversified Healthcare Trust

Actions
  • Price (EUR)5.31
  • Today's Change0.008 / 0.15%
  • Shares traded300.00
  • 1 Year change+108.43%
  • Beta2.3959
Data delayed at least 15 minutes, as of Feb 10 2026 16:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Diversified Healthcare Trust is a real estate investment trust (REIT). The Company is focused on owning healthcare properties located throughout the United States. It has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The Company's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.

  • Revenue in USD (TTM)1.54bn
  • Net income in USD-352.11m
  • Incorporated1998
  • Employees0.00
  • Location
    Diversified Healthcare TrustC/O The Rmr GroupTwo Newton Pl., 255 Wash. St., Ste. 300NEWTON 02458United StatesUSA
  • Phone+1 (617) 796-8350
  • Fax+1 (617) 796-8349
  • Websitehttps://www.dhcreit.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.